We discuss a study on the use of the mu-opioid receptor
antagonist, samidorphan for olanzapine-induced weight gain,
compared to placebo and naltrexone.
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from lectures. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.